You have 9 free searches left this month | for more free features.

BMT - bone marrow transplant

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bone Marrow Transplantation, Bone Marrow Disease Trial in Chapel Hill (physical and occupational therapy consultation)

Not yet recruiting
  • Bone Marrow Transplantation
  • Bone Marrow Disease
  • physical and occupational therapy consultation
  • Chapel Hill, North Carolina
    Lineberger Comphrehensive Cancer Center at University of North C
Aug 4, 2023

Bone Marrow Transplant Complications Trial in Boston (BMT-VR)

Recruiting
  • Bone Marrow Transplant Complications
  • BMT-VR
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

Recruiting
  • Primary Immune Deficiency Disorder
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 20, 2022

Severe Aplastic Anemia Trial in Boston, Salt Lake City (drug, procedure, radiation)

Recruiting
  • Severe Aplastic Anemia
  • Boston, Massachusetts
  • +1 more
Jan 13, 2023

Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)

Recruiting
  • Sickle Cell Disease
  • Bone Marrow Transplant (BMT)
  • +7 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Sep 13, 2022

Leukemia Trial in Aurora (BioIntelliSense BioButton Rechargable, Memora Health two-way patient engagement platform provided by

Recruiting
  • Leukemia
  • BioIntelliSense BioButton Rechargable
  • Memora Health two-way patient engagement platform provided by RC
  • Aurora, Colorado
    University of Colorado Hospital
Apr 20, 2023

Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))

Recruiting
  • Leukemia
  • +5 more
  • Bone Marrow Transplant (BMT)
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022

Sickle Cell Disease Trial in United States (Hematopoietic Stem Cell Transplantation)

Completed
  • Sickle Cell Disease
  • Hematopoietic Stem Cell Transplantation
  • Birmingham, Alabama
  • +18 more
Dec 7, 2022

Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United

Recruiting
  • Bone Marrow Failure Syndrome
  • +6 more
  • Los Angeles, California
  • +23 more
Aug 15, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Dec 13, 2022

Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,

Recruiting
  • Severe Sickle Cell Disease
  • +5 more
  • RIC regimen
  • GVHD prophylaxis regimen
  • New Haven, Connecticut
  • +1 more
Feb 4, 2022

Primary Immunodeficiency, PID Trial in Pittsburgh (CD3/CD19 neg allogeneic BMT)

Active, not recruiting
  • Primary Immunodeficiency
  • PID
  • CD3/CD19 neg allogeneic BMT
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of University of Pittsburgh Me
Oct 6, 2021

Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow

Available
  • Benign Neoplasm
  • +3 more
  • Bone Marrow Transplantation
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 9, 2021

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Bone Marrow Hematopoeitic Cell Transplant (HCT)
  • +9 more
  • (no location specified)
Sep 27, 2021

Bone Marrow Transplantation Trial in Lexington (BMT Physical Activity app, Watch Only)

Recruiting
  • Bone Marrow Transplantation
  • BMT Physical Activity app
  • Watch Only
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Apr 26, 2021

Sickle Cell Disease Trial in United States (Busulfan, Fludarabine, r-ATG)

Active, not recruiting
  • Sickle Cell Disease
  • Oakland, California
  • +34 more
Sep 21, 2022

Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid

Recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +3 more
  • Fludarabine Phosphate
  • +9 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 7, 2022

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Baltimore (Bone Marrow Transplantation, Sorafenib, Sorafenib Tosylate)

Completed
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Bone Marrow Transplantation
  • +2 more
  • Baltimore, Maryland
  • +1 more
May 27, 2021

Bone Marrow Failure Syndromes Trial in Philadelphia (MRD-BMT with Fludarabine-based RIC for Acquired AA, MRD-BMT with

Recruiting
  • Bone Marrow Failure Syndromes
  • MRD-BMT with Fludarabine-based RIC for Acquired AA
  • +2 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
May 6, 2022

Bone Marrow Transplant Trial in Aurora (BioIntellisense BioSticker)

Completed
  • Bone Marrow Transplant
  • BioIntellisense BioSticker
  • Aurora, Colorado
    University of Colorado Hospital
Dec 14, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Total-Body Irradiation
  • +8 more
  • Los Angeles, California
  • +9 more
Aug 19, 2022

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid

Recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +11 more
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 24, 2022

Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +3 more
  • Allogeneic Bone Marrow Transplantation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022